Skip to main content

ꯕ꯭ꯔꯦꯁ꯭ꯠ ꯀꯦꯟꯁꯔ ꯂꯥꯌꯦꯡꯕꯗꯥ ꯁꯤꯖꯤꯟꯅꯕꯥ ꯑꯈꯟꯅꯕꯥ ꯚꯦꯛꯁꯤꯟ ꯑꯃꯥ ꯑꯣꯏꯔꯤꯕꯥ PHESGO (Pertuzumab; Trastuzumab; Hyaluronidase)ꯒꯤ ꯃꯔꯃꯗꯥ ꯈꯪꯖꯤꯅꯕꯤꯌꯨ꯫

ꯕ꯭ꯔꯦꯁ꯭ꯠ ꯀꯦꯟꯁꯔ ꯂꯥꯌꯦꯡꯕꯗꯥ ꯁꯤꯖꯤꯟꯅꯕꯥ ꯑꯈꯟꯅꯕꯥ ꯚꯦꯛꯁꯤꯟ ꯑꯃꯥ ꯑꯣꯏꯔꯤꯕꯥ PHESGO (Pertuzumab; Trastuzumab; Hyaluronidase)ꯒꯤ ꯃꯔꯃꯗꯥ ꯈꯪꯖꯤꯅꯕꯤꯌꯨ꯫

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛ ꯅꯠꯠꯔꯒꯥ ꯅꯍꯥꯛꯀꯥ ꯅꯛꯅꯕꯥ ꯃꯤꯑꯣꯏ ꯑꯃꯅꯥ ꯕ꯭ꯔꯦꯁ꯭ꯠ ꯀꯦꯟꯁꯔꯒꯤ ꯂꯥꯏꯌꯦꯡ ꯆꯠꯊꯔꯕꯗꯤ, ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯅꯍꯥꯀꯄꯨ PHESGO ꯀꯧꯕꯥ ꯚꯦꯛꯁꯤꯟ ꯑꯃꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯋꯥꯔꯤ ꯁꯥꯅꯔꯝꯕꯥ ꯌꯥꯏ꯫ ꯃꯃꯤꯡ ꯑꯁꯤ ꯈꯔꯥ ꯍꯦꯟꯅꯥ ꯂꯨꯝꯂꯕꯁꯨ, ꯇꯁꯦꯡꯕꯗꯤ ꯃꯁꯤ ꯕ꯭ꯔꯦꯁ꯭ꯠ ꯀꯦꯟꯁꯔ ꯂꯥꯌꯦꯡꯕꯗꯥ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯍꯤꯗꯥꯛ ꯀꯌꯥꯒꯤ ꯀꯝꯕꯤꯅꯦꯁꯟ ꯑꯃꯅꯤ꯫ ꯑꯗꯨꯅꯥ ꯉꯁꯤꯗꯤ ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯏꯆꯝ ꯆꯝꯅꯥ ꯋꯥꯔꯤ ꯁꯥꯁꯤ, ꯃꯔꯨꯞ ꯑꯃꯒꯥ ꯋꯥꯔꯤ ꯁꯥꯅꯔꯀꯄꯒꯨꯝ, ꯑꯃꯁꯨꯡ ꯄꯨꯝꯅꯃꯛ ꯃꯌꯦꯛ ꯁꯦꯡꯅꯥ ꯈꯉꯂꯁꯤ꯫

ꯃꯁꯤ ꯐꯦꯁꯒꯣ ꯑꯁꯤ ꯇꯁꯦꯡꯅꯥ ꯀꯔꯤꯅꯣ?

ꯌꯥꯝꯅꯥ ꯂꯥꯏꯅꯥ ꯍꯥꯌꯔꯕꯗꯥ, ꯐꯦꯁꯒꯣ ꯑꯁꯤ ꯗ꯭ꯔꯒ ꯑꯍꯨꯃꯒꯤ ꯀꯝꯕꯤꯅꯦꯁꯟ ꯑꯃꯅꯤ꯫ ꯃꯈꯣꯌꯁꯤꯡ ꯑꯗꯨꯗꯤ ꯄꯦꯔꯇꯨꯖꯨꯃꯕ , ꯇ꯭ꯔꯥꯁ꯭ꯇꯨꯖꯨꯃꯕ ꯑꯃꯁꯨꯡ ꯍꯥꯏꯑꯦꯂꯨꯔꯣꯅꯤꯗꯦꯖꯅꯤ ꯫ ꯍꯧꯖꯤꯛ ꯃꯁꯤ ꯑꯃꯃꯃꯗꯥ ꯀꯔꯤ ꯑꯣꯏꯔꯤꯕꯒꯦ ꯍꯥꯌꯕꯗꯨ ꯌꯦꯡꯁꯤ꯫

  • ꯄꯦꯔꯇꯨꯖꯨꯃꯕ ꯑꯃꯁꯨꯡ ꯇ꯭ꯔꯥꯁ꯭ꯇꯨꯖꯨꯃꯕ: ꯍꯥꯌꯔꯤꯕꯥ ꯑꯅꯤꯃꯛ ꯑꯁꯤ ꯑꯈꯟꯅꯕꯥ ꯃꯈꯂꯒꯤ ꯄ꯭ꯔꯣꯇꯤꯅꯁꯤꯡꯅꯤ꯫ ꯃꯦꯗꯤꯁꯤꯅꯗꯥ ꯑꯩꯈꯣꯌꯅꯥ ꯍꯥꯌꯔꯤꯕꯥ ꯃꯣꯅꯣꯛꯂꯣꯅꯦꯜ ꯑꯦꯟꯇꯤꯕꯣꯗꯤꯁꯤꯡ ꯑꯁꯤ . ꯃꯈꯣꯌꯁꯤꯡ ꯑꯁꯤ ꯄꯥꯟꯗꯝ ꯑꯗꯨꯗꯥ ꯊꯦꯡꯅꯔꯤꯕꯥ ꯃꯤꯁꯥꯏꯜ ꯑꯅꯤ ꯑꯣꯏꯅꯥ ꯈꯅꯕꯤꯌꯨ꯫ ꯃꯈꯣꯌꯅꯥ ꯑꯩꯈꯣꯌꯒꯤ ꯍꯀꯆꯥꯡꯗꯥ ꯆꯪꯂꯀꯄꯥ ꯃꯇꯃꯗꯥ ꯃꯈꯣꯌꯅꯥ ꯀꯦꯟꯁꯔ ꯁꯦꯂꯁꯤꯡ ꯊꯤꯅꯕꯥ ꯍꯀꯊꯦꯡꯅꯅꯥ ꯆꯠꯂꯤ꯫ ꯃꯈꯣꯌꯅꯥ ꯀꯦꯟꯁꯔ ꯁꯦꯂꯁꯤꯡ ꯑꯗꯨꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯆꯦꯜꯂꯤ, ꯃꯈꯣꯌꯕꯨ ꯍꯦꯅꯒꯠꯂꯀꯄꯥ ꯊꯤꯡꯏ ꯅꯠꯠꯔꯒꯥ ꯃꯥꯡꯍꯟ ꯇꯥꯀꯍꯅꯕꯥ ꯐꯥꯎꯏ꯫ ꯍꯥꯌꯔꯤꯕꯁꯤꯡ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯏꯐꯦꯛꯇꯤꯕ ꯑꯣꯏꯕꯥ ꯂꯥꯌꯦꯡꯁꯤꯡꯅꯤ ꯃꯔꯃꯗꯤ ꯃꯈꯣꯌꯅꯥ ꯍꯀꯆꯥꯡ ꯐꯕꯥ ꯁꯦꯂꯁꯤꯡꯗꯥ ꯌꯥꯝꯅꯥ ꯑꯃꯥꯡ-ꯑꯇꯥ ꯊꯣꯀꯍꯟꯗꯅꯥ ꯀꯦꯟꯁꯔ ꯁꯦꯜ ꯈꯛꯇꯗꯥ ꯄꯥꯟꯗꯝ ꯊꯝꯂꯤ꯫
  • ꯍꯥꯌꯑꯦꯂꯨꯔꯣꯅꯤꯗꯦꯖ: ꯃꯁꯤ ꯑꯍꯨꯃꯁꯨꯕꯥ ꯑꯃꯅꯤ꯫ ꯃꯁꯤꯅꯥ ꯇꯧꯔꯤꯕꯥ ꯑꯁꯤ ꯃꯊꯛꯇꯥ ꯄꯅꯈ꯭ꯔꯤꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯅꯤ ꯑꯁꯤ ꯑꯩꯈꯣꯌꯒꯤ ꯍꯀꯆꯥꯡꯅꯥ ꯍꯦꯟꯅꯥ ꯐꯅꯥ ꯁꯣꯀꯍꯅꯕꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯏ꯫ ꯅꯣꯔꯃꯦꯜ ꯑꯣꯏꯅꯥ, ꯍꯤꯗꯥꯛ ꯑꯅꯤ ꯑꯗꯨ ꯏꯅꯠꯔꯥꯚꯦꯅꯁ ꯑꯣꯏꯅꯥ (ꯚꯦꯟ ꯑꯃꯗꯥ) ꯄꯤꯕꯗꯥ ꯃꯇꯝ ꯁꯥꯡꯅꯥ ꯆꯪꯏ꯫ ꯑꯗꯨꯕꯨ ꯍꯥꯌꯑꯦꯂꯨꯔꯣꯅꯤꯗꯦꯖ ꯀꯧꯕꯥ ꯑꯁꯤꯅꯥ ꯃꯔꯝ ꯑꯣꯏꯗꯨꯅꯥ ꯍꯤꯗꯥꯛ ꯑꯅꯤꯃꯛ ꯑꯁꯤ ꯈꯣꯡꯒꯤ ꯃꯈꯥꯗꯥ ꯏꯆꯝ ꯆꯝꯕꯥ ꯏꯅꯖꯦꯀꯁꯟ ꯑꯃꯥ ꯑꯣꯏꯅꯥ ꯑꯃꯨꯛ ꯍꯟꯅꯥ ꯄꯤꯕꯥ ꯉꯃꯈ꯭ꯔꯦ꯫ ꯃꯁꯤꯅꯥ ꯑꯅꯥꯕꯥ ꯑꯗꯨꯒꯤꯗꯃꯛ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯂꯩꯕꯥ ꯅꯨꯡꯉꯥꯏꯇꯕꯥ ꯑꯃꯁꯨꯡ ꯃꯇꯝ ꯌꯥꯝꯅꯥ ꯍꯟꯊꯍꯜꯂꯤ꯫

ꯑꯗꯨꯅꯥ, ꯃꯤꯑꯣꯏ ꯑꯍꯨꯝ ꯑꯁꯤꯅꯥ ꯄꯨꯟꯅꯥ ꯂꯥꯀꯃꯤꯟꯅꯗꯨꯅꯥ ꯐꯦꯁꯒꯣ ꯀꯧꯕꯥ ꯁꯛꯇꯤ ꯂꯩꯔꯕꯥ ꯂꯥꯌꯦꯡ ꯑꯁꯤ ꯁꯦꯃꯒꯠꯂꯤ꯫

ꯂꯥꯏꯌꯦꯡ ꯍꯧꯗ꯭ꯔꯤꯉꯩꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯍꯧꯗ꯭ꯔꯤꯉꯩꯒꯤ ꯃꯃꯥꯡꯗꯥ, ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯃꯠꯇꯥ ꯂꯣꯠꯁꯤꯟꯗꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯃꯄꯨꯡꯐꯥꯕꯥ ꯍꯀꯁꯦꯂꯒꯤ ꯍꯤꯁ꯭ꯇꯔꯤ ꯑꯗꯨ ꯈꯟꯅ-ꯅꯩꯅꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯈꯥꯗꯥ ꯄꯤꯔꯤꯕꯥ ꯀꯟꯗꯤꯁꯅꯁꯤꯡ ꯑꯁꯤꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯑꯃꯍꯦꯛꯇꯥ ꯂꯩꯔꯕꯗꯤ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯁꯣꯌꯗꯅꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ:

  • ꯍꯥꯔꯠ ꯗꯤꯖꯤꯖ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯃꯥꯡꯗꯥ ꯂꯩꯔꯝꯕꯥ ꯍꯥꯔꯇꯀꯤ ꯀꯟꯗꯤꯁꯟ ꯑꯃꯥ ꯅꯠꯠꯔꯒꯥ ꯍꯥꯔꯠ ꯐꯦꯜ ꯑꯣꯏꯕꯥ ꯑꯣꯏꯔꯕꯗꯤ꯫
  • ꯍꯥꯏ ꯕ꯭ꯂꯗ ꯄ꯭ꯔꯦꯁꯔ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯍꯥꯏ ꯕ꯭ꯂꯗ ꯄ꯭ꯔꯦꯁꯔ ꯂꯩꯔꯕꯗꯤ꯫
  • ꯍꯥꯔꯇꯀꯤ ꯈꯣꯡꯖꯦꯜ ꯌꯥꯡꯕꯥ (irregular heartbeat): ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯃꯥꯡꯗꯥ ꯀꯩꯗꯧꯉꯩꯗꯥ ꯑꯦꯕꯅꯣꯔꯃꯦꯜ ꯑꯣꯏꯕꯥ ꯍꯥꯔꯇꯀꯤ ꯈꯣꯟꯖꯦꯜ ꯑꯃꯥ ꯂꯩꯔꯝꯂꯕꯗꯤ꯫
  • ꯂꯪꯁ ꯅꯠꯠꯔꯒꯥ ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯒꯤ ꯂꯥꯌꯅꯥꯁꯤꯡ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯒꯤ ꯂꯥꯌꯅꯥꯁꯤꯡ ꯍꯥꯌꯕꯗꯤ ꯑꯦꯖꯃꯥ ꯂꯩꯔꯕꯗꯤ꯫
  • ꯑꯦꯂꯥꯔꯖꯤ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯀꯁꯤꯡ ꯑꯁꯤꯈꯛꯇꯗꯥ ꯅꯠꯇꯅꯥ ꯑꯇꯩ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯀꯁꯤꯡ, ꯆꯤꯟꯖꯥꯀꯁꯤꯡ, ꯗꯥꯏꯑꯦꯠꯁꯤꯡ ꯅꯠꯠꯔꯒꯥ ꯄ꯭ꯔꯤꯖꯥꯔꯕ ꯇꯧꯕꯥ ꯌꯥꯕꯥ ꯄꯣꯠꯁꯀꯁꯤꯡꯒꯤ ꯑꯦꯂꯥꯔꯖꯤ ꯂꯩꯔꯕꯗꯤ ꯑꯩꯈꯣꯌꯗꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ꯫
  • ꯃꯤꯔꯣꯅꯕꯥ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯤꯔꯣꯜꯂꯤꯕꯥ, ꯃꯤꯔꯣꯅꯕꯥ ꯍꯣꯠꯅꯔꯕꯗꯤ ꯅꯠꯠꯔꯒꯥ ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯋꯥꯈꯜ ꯋꯥꯕꯥ ꯂꯩꯔꯕꯗꯤ ꯃꯁꯤ ꯃꯔꯨꯑꯣꯏꯅꯥ ꯃꯔꯨꯑꯣꯏ . ꯑꯃꯁꯨꯡ ꯇꯁꯦꯡꯕꯗꯤ, ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯈꯣꯝꯂꯥꯡ ꯄꯤꯊꯀꯄꯥ ꯃꯃꯥ ꯑꯃꯥ ꯑꯣꯏꯔꯕꯗꯤ .

ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯑꯁꯤ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯄꯤꯕꯅꯥ ꯃꯍꯥꯀꯄꯨ ꯁꯥꯐꯅꯥ ꯑꯃꯁꯨꯡ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯏꯐꯦꯛꯇꯤꯚ ꯑꯣꯏꯅꯥ ꯂꯥꯏꯌꯦꯡꯕꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯒꯅꯤ꯫

ꯃꯁꯤꯒꯤ ꯚꯦꯛꯁꯤꯟ ꯑꯁꯤ ꯀꯔꯝꯅꯥ ꯄꯤꯕꯒꯦ ꯑꯃꯁꯨꯡ ꯅꯍꯥꯛꯅꯥ ꯈꯪꯖꯤꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯈꯣꯡꯒꯤ ꯃꯈꯥꯗꯥ ꯏꯅꯖꯦꯀꯁꯟ ꯑꯃꯥ ꯑꯣꯏꯅꯥ ꯄꯤ꯫ ꯃꯁꯤ ꯃꯍꯧꯁꯥꯅꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯜ ꯅꯠꯠꯔꯒꯥ ꯀ꯭ꯂꯤꯅꯤꯛ ꯑꯃꯗꯥ ꯇ꯭ꯔꯦꯟ ꯇꯧꯔꯕꯥ ꯃꯦꯗꯤꯀꯦꯜ ꯄ꯭ꯔꯣꯐꯦꯁꯅꯦꯜ ꯑꯃꯅꯥ ꯄꯤ꯫ ꯑꯗꯨꯝ ꯑꯣꯏꯅꯃꯛ, ꯀꯦꯁ ꯈꯔꯗꯗꯤ ꯇ꯭ꯔꯦꯟ ꯇꯧꯔꯕꯥ ꯍꯦꯂꯊ ꯋꯥꯔꯀꯔ ꯑꯃꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯌꯨꯃꯗꯥ ꯂꯥꯛꯇꯨꯅꯥ ꯚꯦꯛꯁꯤꯟ ꯑꯗꯨ ꯄꯤꯕꯥ ꯌꯥꯏ꯫

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯩꯅꯥ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛꯀꯤ ꯗꯣꯖ ꯑꯃꯥ ꯁꯣꯟꯊꯔꯕꯗꯤ ꯀꯔꯤ ꯇꯧꯒꯅꯤ?

ꯂꯥꯏꯌꯦꯡ ꯑꯁꯤꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯇꯤꯀꯥ ꯑꯁꯤ ꯃꯇꯝ ꯆꯥꯅꯥ ꯂꯧꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯔꯝ ꯈꯔꯗꯒꯤ ꯅꯍꯥꯛꯅꯥ ꯇꯤꯀꯥ ꯑꯗꯨ ꯃꯇꯝ ꯆꯥꯅꯥ ꯂꯧꯕꯥ ꯉꯃꯗ꯭ꯔꯕꯗꯤ, ꯈꯨꯗꯛꯇꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯐꯣꯟ ꯇꯧꯕꯤꯌꯨ ꯑꯃꯁꯨꯡ ꯃꯈꯣꯌꯗꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ꯫

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯩꯅꯥ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛ ꯌꯥꯝꯅꯥ ꯂꯧꯔꯕꯗꯤ ꯀꯔꯤ ꯇꯧꯒꯅꯤ?

ꯃꯁꯤ ꯃꯍꯧꯁꯥꯅꯥ ꯑꯣꯏꯗꯦ, ꯃꯔꯃꯗꯤ ꯃꯁꯤ ꯄ꯭ꯔꯣꯐꯦꯁꯅꯦꯜ ꯑꯃꯅꯥ ꯑꯦꯗꯃꯤꯅꯤꯁ꯭ꯠꯔꯦꯠ ꯇꯧꯏ꯫ ꯑꯗꯨꯝ ꯑꯣꯏꯅꯃꯛ, ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯑꯣꯡ ꯑꯃꯗꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯊꯀꯈ꯭ꯔꯦ ꯍꯥꯌꯅꯥ ꯈꯜꯂꯕꯗꯤ, ꯋꯥꯈꯜ ꯅꯨꯡꯉꯥꯏꯇꯕꯥ ꯂꯩꯔꯣꯏꯗꯕꯅꯤ ꯑꯃꯁꯨꯡ ꯈꯨꯗꯛꯇꯥ ꯀꯣꯂꯝꯕꯣ ꯅꯦꯁꯅꯦꯜ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯂꯩꯕꯥ ꯅꯦꯁꯅꯦꯜ ꯄꯣꯏꯖꯅꯁ ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯁꯦꯟꯇꯔꯗꯥ ꯐꯣꯟ ꯇꯧꯕꯤꯌꯨ . ꯅꯠꯠꯔꯒꯥ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯅꯀꯄꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯒꯤ ꯏꯃꯔꯖꯦꯟꯁꯤ ꯇ꯭ꯔꯤꯇꯃꯦꯟꯇ ꯌꯨꯅꯤꯠ (ETU)ꯗꯥ ꯆꯠꯂꯨ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯑꯉꯥꯡꯁꯤꯡꯗꯥ ꯄꯤꯕꯥ ꯉꯃꯒꯗ꯭ꯔꯥ?

ꯃꯁꯤꯒꯤ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯃꯍꯧꯁꯥꯅꯥ ꯑꯍꯜ ꯑꯣꯏꯔꯕꯥ ꯃꯤꯑꯣꯏꯁꯤꯡꯗꯥ ꯄꯤ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯉꯥꯡꯁꯤꯡꯗꯥ ꯄꯤꯔꯕꯗꯤ ꯑꯈꯟꯅꯕꯥ ꯀꯦꯌꯔ ꯃꯊꯧ ꯇꯥꯏ꯫ ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯑꯉꯥꯡꯒꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯇꯥꯟꯅꯧ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯂꯧꯕꯥ ꯃꯇꯃꯗꯥ ꯃꯔꯨꯑꯣꯏꯅꯥ ꯆꯦꯀꯁꯤꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ:

  • ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯃꯦꯗꯤꯀꯦꯜ ꯆꯦꯀꯑꯞ ꯇꯧꯕꯥ: ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯂꯧꯔꯤꯉꯩꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯇꯥꯀꯄꯤꯔꯀꯄꯒꯤ ꯃꯇꯨꯡꯏꯟꯅꯥ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯆꯦꯀꯑꯞ ꯇꯧꯕꯤꯌꯨ꯫ ꯅꯍꯥꯛꯀꯤ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯑꯗꯨ ꯍꯦꯟꯅꯥ ꯐꯒꯠꯂꯛꯂꯤꯕ꯭ꯔꯥ ꯅꯠꯠꯔꯒꯥ ꯍꯦꯟꯅꯥ ꯐꯒꯠꯂꯛꯂꯤꯕ꯭ꯔꯥ ꯍꯥꯌꯕꯗꯨ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯋꯥꯔꯤ ꯁꯥꯕꯤꯌꯨ꯫ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯍꯥꯔꯇꯀꯤ ꯐꯉ꯭ꯀꯁꯅꯒꯨꯝꯕꯥ ꯄꯣꯠꯁꯀꯁꯤꯡ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯌꯦꯡꯁꯤꯅꯒꯅꯤ꯫
  • ꯃꯤꯔꯣꯅꯕꯥ ꯊꯤꯡꯕꯥ (ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏꯕꯥ): ꯃꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ . ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯆꯥꯔꯤꯉꯩꯗꯥ ꯑꯃꯁꯨꯡ ꯂꯥꯏꯌꯦꯡ ꯂꯦꯄꯈ꯭ꯔꯕꯥ ꯃꯇꯨꯡꯗꯥ ꯊꯥ 7 ꯐꯥꯎꯕꯥ ꯃꯤꯔꯣꯅꯕꯥ ꯊꯤꯡꯒꯗꯕꯅꯤ꯫ ꯍꯤꯗꯥꯛ ꯑꯁꯤꯅꯥ ꯄꯣꯀꯄꯥ ꯑꯉꯥꯡ ꯑꯗꯨꯗꯥ ꯁꯥꯊꯤꯕꯥ ꯑꯃꯥꯡ-ꯑꯇꯥ ꯊꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ꯫ ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯃꯇꯝ ꯑꯁꯤꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯏꯐꯦꯛꯇꯤꯚ ꯑꯣꯏꯕꯥ ꯕꯔꯊ ꯀꯟꯠꯔꯣꯜ ꯃꯦꯊꯗ ꯑꯗꯨꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯇꯥꯟꯅꯧ꯫
  • ꯑꯇꯣꯞꯄꯥ ꯍꯤꯗꯥꯀꯁꯤꯡꯒꯥ ꯏꯟꯇꯔꯦꯛꯁꯅꯁꯤꯡ: ꯅꯍꯥꯛꯅꯥ ꯂꯧꯔꯤꯕꯥ ꯑꯇꯩ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯀꯁꯤꯡ, ꯍꯔꯕꯁ, ꯚꯤꯇꯥꯃꯤꯅꯁꯤꯡ ꯑꯃꯁꯨꯡ ꯁꯞꯂꯤꯃꯦꯟꯇꯁꯤꯡꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯜꯂꯨ꯫ ꯀꯦꯃꯣꯊꯦꯔꯥꯄꯤ ꯗ꯭ꯔꯒ ꯈꯔꯗꯤ, ꯍꯥꯌꯕꯗꯤ ꯗꯥꯎꯅꯣꯔꯨꯕꯤꯁꯤꯟ, ꯗꯣꯛꯁꯣꯔꯨꯕꯤꯁꯤꯟ, ꯑꯃꯁꯨꯡ ꯑꯦꯄꯤꯔꯨꯕꯤꯁꯤꯅꯅꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯏꯟꯇꯔꯦꯛꯇ ꯇꯧꯕꯥ ꯌꯥꯏ꯫ ꯅꯍꯥꯛꯅꯥ ꯂꯧꯔꯤꯕꯥ ꯈꯨꯗꯤꯡꯃꯛ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫

ꯍꯤꯗꯥꯛ ꯑꯗꯨꯒꯤ ꯑꯣꯏꯊꯣꯀꯄꯥ ꯌꯥꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯁꯤꯡ ꯑꯗꯨ ꯀꯔꯤꯅꯣ?

ꯍꯤꯗꯥꯛ ꯑꯃꯍꯦꯛꯇꯒꯨꯝꯅꯥ, ꯃꯁꯤꯒꯤ ꯑꯃꯅꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ ꯈꯔꯥ ꯊꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ꯫ ꯑꯗꯨꯕꯨ ꯃꯤꯄꯨꯝ ꯈꯨꯗꯤꯡꯃꯛꯅꯥ ꯃꯈꯣꯌꯁꯤꯡ ꯑꯁꯤ ꯐꯪꯗꯦ꯫ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯋꯥꯐꯃꯗꯤ ꯑꯗꯨꯒꯨꯝꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯁꯤꯡ ꯑꯗꯨ ꯀꯔꯤꯅꯣ ꯑꯃꯁꯨꯡ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯈꯣꯌ ꯊꯣꯛꯂꯕꯗꯤ ꯀꯔꯤ ꯇꯧꯒꯗꯒꯦ ꯍꯥꯌꯕꯗꯨ ꯈꯪꯖꯤꯅꯕꯥ ꯑꯁꯤꯅꯤ꯫

ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ꯫ ꯃꯁꯛ ꯈꯪꯗꯣꯀꯄꯥ ꯑꯃꯁꯨꯡ ꯀꯔꯤ ꯇꯧꯒꯗꯒꯦ꯫
ꯈꯨꯗꯛꯇꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯔꯤꯄꯣꯔꯠ ꯇꯧꯒꯗꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯁꯤꯡ꯫
ꯑꯦꯂꯥꯔꯖꯤꯒꯤ ꯔꯤꯑꯦꯛꯁꯅꯁꯤꯡ꯫ ꯈꯣꯡ-ꯈꯨꯠ ꯁꯣꯛ-ꯄꯅꯕꯥ, ꯈꯣꯡ-ꯈꯨꯠ ꯁꯣꯛ-ꯄꯅꯕꯥ, ꯃꯥꯌ, ꯊꯕꯥꯛ ꯅꯠꯠꯔꯒꯥ ꯈꯣꯡꯗꯥ ꯁꯣꯀꯄꯥ꯫
ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯥ ꯋꯥꯕꯥ꯫ ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯥ ꯋꯥꯕꯥ, ꯈꯣꯡ ꯍꯥꯝꯕꯥ, ꯀꯣꯛ ꯆꯤꯀꯄꯥ꯫
ꯍꯥꯔꯇꯀꯤ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ꯫ ꯈꯣꯡꯗꯥ ꯁꯣꯀꯄꯥ, ꯈꯣꯡ ꯍꯥꯝꯕꯥ, ꯈꯪꯍꯧꯗꯅꯥ ꯑꯔꯨꯝꯕꯥ ꯍꯦꯅꯒꯠꯂꯀꯄꯥ, ꯈꯣꯡ ꯅꯠꯠꯔꯒꯥ ꯈꯣꯡꯗꯥ ꯁꯣꯀꯄꯥ꯫
ꯑꯇꯣꯞꯄꯥ ꯁꯥꯊꯤꯕꯥ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ꯫ ꯃꯤꯠ ꯎꯗꯕꯥ, ꯋꯥꯈꯜ ꯃꯥꯡꯈꯤꯕꯥ, ꯂꯥꯏꯍꯧ ꯅꯠꯠꯔꯒꯥ ꯆꯤꯀꯄꯥ, ꯃꯁꯥ ꯃꯊꯟꯇꯥ ꯑꯁꯣꯛ-ꯑꯄꯟ ꯊꯣꯀꯄꯥ, ꯃꯁꯥ ꯃꯊꯟꯇꯥ ꯋꯥꯈꯜ ꯇꯥꯗꯕꯥ, ꯑꯆꯝꯕꯥ ꯃꯑꯣꯡꯗꯥ ꯋꯥꯈꯜ ꯇꯥꯗꯕꯥ꯫
ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯗꯨ ꯂꯦꯡꯗꯅꯥ ꯂꯩꯔꯕꯗꯤ ꯅꯠꯠꯔꯒꯥ ꯁꯣꯀꯍꯜꯂꯕꯗꯤ, ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯜꯂꯨ꯫
ꯗꯥꯏꯖꯦꯁ꯭ꯇꯤꯚ ꯁꯤꯁ꯭ꯇꯦꯃꯒꯤ ꯄ꯭ꯔꯣꯕ꯭ꯂꯦꯃꯁꯤꯡ꯫ ꯗꯥꯏꯔꯤꯌꯥ, ꯅꯣꯡꯃꯩ ꯀꯥꯞꯄꯥ, ꯈꯣꯡ ꯍꯥꯝꯕꯥ꯫
ꯍꯀꯆꯥꯡꯒꯤ ꯑꯅꯥꯕꯥ꯫ ꯁꯔꯨ ꯇꯥꯡꯒꯤ ꯑꯅꯥꯕꯥ, ꯃꯁꯜ ꯁꯣꯟꯊꯕꯥ꯫
ꯑꯇꯣꯞꯄꯥ ꯑꯄꯤꯀꯄꯥ ꯐꯤꯆꯔꯁꯤꯡ꯫ꯆꯨꯝꯅꯥ ꯁꯣꯀꯄꯥ, ꯂꯥꯎꯕꯥ, ꯏꯅꯖꯦꯀꯁꯟ ꯇꯧꯔꯤꯕꯥ ꯃꯐꯝ ꯑꯗꯨꯗꯥ ꯁꯣꯀꯄꯥ ꯅꯠꯠꯔꯒꯥ ꯁꯣꯀꯄꯥ, ꯖꯦꯅꯦꯔꯦꯜ ꯐꯤꯖꯤꯀꯦꯜ ꯐꯤꯇꯁ꯫

ꯂꯤꯁ꯭ꯠ ꯑꯁꯤꯗꯥ ꯑꯣꯏꯊꯣꯀꯄꯥ ꯌꯥꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ ꯄꯨꯝꯅꯃꯛ ꯌꯥꯎꯗꯦ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯑꯇꯣꯞꯄꯥ ꯇꯣꯉꯥꯅꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯑꯆꯝꯕꯥ ꯄꯣꯠꯁꯛ ꯑꯃꯥ ꯎꯔꯕꯗꯤ, ꯃꯗꯨꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯇꯥꯟꯅꯧ꯫

ꯇꯦꯛ-ꯍꯣꯝ ꯃꯦꯁꯦꯖ ꯇꯧꯕꯥ꯫

  • PHESGO ꯑꯁꯤ ꯕ꯭ꯔꯦꯁ꯭ꯠ ꯀꯦꯟꯁꯔꯒꯤ ꯑꯀꯛꯅꯕꯥ, ꯄꯥꯟꯗꯝ ꯊꯝꯂꯤꯕꯥ ꯂꯥꯏꯌꯦꯡ ꯑꯃꯅꯤ꯫ ꯃꯁꯤ ꯗ꯭ꯔꯒ ꯑꯍꯨꯃꯒꯤ ꯀꯝꯕꯤꯅꯦꯁꯟ ꯑꯃꯅꯤ꯫
  • ꯂꯥꯏꯌꯦꯡ ꯍꯧꯗ꯭ꯔꯤꯉꯩꯗꯥ, ꯅꯍꯥꯛꯀꯤ ꯍꯀꯁꯦꯂꯒꯤ ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯄꯨꯝꯅꯃꯛ, ꯃꯔꯨꯑꯣꯏꯅꯥ ꯍꯥꯔꯇꯀꯤ ꯂꯥꯌꯅꯥ, ꯑꯦꯂꯥꯔꯖꯤ ꯑꯃꯁꯨꯡ ꯃꯤꯔꯣꯅꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯜꯂꯨ꯫
  • ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯂꯧꯔꯤꯉꯩꯗꯥ ꯑꯃꯁꯨꯡ ꯊꯀꯄꯥ ꯂꯣꯏꯔꯕꯥ ꯃꯇꯨꯡꯗꯥ ꯊꯥ 7 ꯐꯥꯎꯕꯥ ꯃꯤꯔꯣꯅꯕꯥ ꯊꯤꯡꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫ ꯃꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫
  • ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯥ ꯋꯥꯕꯥ, ꯈꯣꯡꯗꯥ ꯁꯣꯀꯄꯥ, ꯅꯠꯠꯔꯒꯥ ꯃꯥꯌ ꯁꯣꯀꯄꯥ ꯑꯁꯤꯅꯆꯤꯡꯕꯥ ꯁꯥꯊꯤꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ ꯑꯃꯠꯇꯥ ꯂꯩꯔꯕꯗꯤ ꯈꯨꯗꯛꯇꯥ ꯃꯦꯗꯤꯀꯦꯂꯒꯤ ꯄꯥꯎꯇꯥꯛ ꯂꯧꯕꯤꯌꯨ꯫
  • ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯀꯟꯇꯦꯛꯇ ꯇꯧꯗꯨꯅꯥ ꯂꯩꯌꯨ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯀꯤ ꯋꯥꯍꯪꯁꯤꯡ ꯅꯠꯠꯔꯒꯥ ꯋꯥꯈꯜ ꯅꯨꯡꯉꯥꯏꯇꯕꯥ ꯑꯃꯠꯇꯥ ꯂꯩꯔꯕꯗꯤ ꯍꯪꯕꯗꯥ ꯂꯥꯡꯇꯛꯅꯒꯅꯨ꯫ ꯅꯍꯥꯛꯀꯤ ꯌꯥꯏꯐ-ꯊꯧꯔꯥꯡ ꯑꯁꯤ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯃꯔꯨꯑꯣꯏꯕꯅꯤ꯫

PHESGO, Pertuzumab, Trastuzumab, Hyaluronidase, ꯕ꯭ꯔꯦꯁ꯭ꯠ ꯀꯦꯟꯁꯔ, ꯀꯦꯟꯁꯔ ꯂꯥꯌꯦꯡꯕꯥ, ꯃꯣꯅꯣꯛꯂꯣꯅꯦꯜ ꯑꯦꯟꯇꯤꯕꯣꯗꯤ, ꯀꯦꯟꯁꯔ ꯗ꯭ꯔꯒꯁꯤꯡ, ꯅꯨꯄꯤꯁꯤꯡꯒꯤ ꯍꯀꯁꯦꯜ꯫

Frequently Asked Questions (FAQ)

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯑꯉꯥꯡꯁꯤꯡꯗꯥ ꯄꯤꯕꯥ ꯉꯃꯒꯗ꯭ꯔꯥ?

ꯃꯁꯤꯒꯤ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯃꯍꯧꯁꯥꯅꯥ ꯑꯍꯜ ꯑꯣꯏꯔꯕꯥ ꯃꯤꯑꯣꯏꯁꯤꯡꯗꯥ ꯄꯤ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯉꯥꯡꯁꯤꯡꯗꯥ ꯄꯤꯔꯕꯗꯤ ꯑꯈꯟꯅꯕꯥ ꯀꯦꯌꯔ ꯃꯊꯧ ꯇꯥꯏ꯫ ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯑꯉꯥꯡꯒꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯇꯥꯟꯅꯧ꯫

⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No comments yet. Be the first to share your thoughts here.

Add Your Comment

Please calculate: 7 + 6 =
ꯕ꯭ꯔꯦꯁ꯭ꯠ ꯀꯦꯟꯁꯔ ꯂꯥꯌꯦꯡꯕꯗꯥ ꯁꯤꯖꯤꯟꯅꯕꯥ ꯑꯈꯟꯅꯕꯥ ꯚꯦꯛꯁꯤꯟ ꯑꯃꯥ ꯑꯣꯏꯔꯤꯕꯥ PHESGO (Pertuzumab; Trastuzumab; Hyaluronidase)ꯒꯤ ꯃꯔꯃꯗꯥ ꯈꯪꯖꯤꯅꯕꯤꯌꯨ꯫
ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯀꯁꯤꯡ꯫জুলাই ৬, ২০২৬

ꯕ꯭ꯔꯦꯁ꯭ꯠ ꯀꯦꯟꯁꯔ ꯂꯥꯌꯦꯡꯕꯗꯥ ꯁꯤꯖꯤꯟꯅꯕꯥ ꯑꯈꯟꯅꯕꯥ ꯚꯦꯛꯁꯤꯟ ꯑꯃꯥ ꯑꯣꯏꯔꯤꯕꯥ PHESGO (Pertuzumab; Trastuzumab; Hyaluronidase)ꯒꯤ ꯃꯔꯃꯗꯥ ꯈꯪꯖꯤꯅꯕꯤꯌꯨ꯫

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛ ꯅꯠꯠꯔꯒꯥ ꯅꯍꯥꯛꯀꯥ ꯅꯛꯅꯕꯥ ꯃꯤꯑꯣꯏ ꯑꯃꯅꯥ ꯕ꯭ꯔꯦꯁ꯭ꯠ ꯀꯦꯟꯁꯔꯒꯤ ꯂꯥꯏꯌꯦꯡ ꯆꯠꯊꯔꯕꯗꯤ, ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯅꯍꯥꯀꯄꯨ PHESGO ꯀꯧꯕꯥ ꯚꯦꯛꯁꯤꯟ ꯑꯃꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯋꯥꯔꯤ ꯁꯥꯅꯔꯝꯕꯥ ꯌꯥꯏ꯫ ꯃꯃꯤꯡ ꯑꯁꯤ ꯈꯔꯥ ꯍꯦꯟꯅꯥ ꯂꯨꯝꯂꯕꯁꯨ, ꯇꯁꯦꯡꯕꯗꯤ ꯃꯁꯤ ꯕ꯭ꯔꯦꯁ꯭ꯠ ꯀꯦꯟꯁꯔ ꯂꯥꯌꯦꯡꯕꯗꯥ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯍꯤꯗꯥꯛ ꯀꯌꯥꯒꯤ ꯀꯝꯕꯤꯅꯦꯁꯟ ꯑꯃꯅꯤ꯫ ꯑꯗꯨꯅꯥ ꯉꯁꯤꯗꯤ ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯏꯆꯝ ꯆꯝꯅꯥ ꯋꯥꯔꯤ ꯁꯥꯁꯤ, ꯃꯔꯨꯞ ꯑꯃꯒꯥ ꯋꯥꯔꯤ ꯁꯥꯅꯔꯀꯄꯒꯨꯝ, ꯑꯃꯁꯨꯡ ꯄꯨꯝꯅꯃꯛ ꯃꯌꯦꯛ ꯁꯦꯡꯅꯥ ꯈꯉꯂꯁꯤ꯫

ꯃꯁꯤ ꯐꯦꯁꯒꯣ ꯑꯁꯤ ꯇꯁꯦꯡꯅꯥ ꯀꯔꯤꯅꯣ?

ꯌꯥꯝꯅꯥ ꯂꯥꯏꯅꯥ ꯍꯥꯌꯔꯕꯗꯥ, ꯐꯦꯁꯒꯣ ꯑꯁꯤ ꯗ꯭ꯔꯒ ꯑꯍꯨꯃꯒꯤ ꯀꯝꯕꯤꯅꯦꯁꯟ ꯑꯃꯅꯤ꯫ ꯃꯈꯣꯌꯁꯤꯡ ꯑꯗꯨꯗꯤ ꯄꯦꯔꯇꯨꯖꯨꯃꯕ , ꯇ꯭ꯔꯥꯁ꯭ꯇꯨꯖꯨꯃꯕ ꯑꯃꯁꯨꯡ ꯍꯥꯏꯑꯦꯂꯨꯔꯣꯅꯤꯗꯦꯖꯅꯤ ꯫ ꯍꯧꯖꯤꯛ ꯃꯁꯤ ꯑꯃꯃꯃꯗꯥ ꯀꯔꯤ ꯑꯣꯏꯔꯤꯕꯒꯦ ꯍꯥꯌꯕꯗꯨ ꯌꯦꯡꯁꯤ꯫

  • ꯄꯦꯔꯇꯨꯖꯨꯃꯕ ꯑꯃꯁꯨꯡ ꯇ꯭ꯔꯥꯁ꯭ꯇꯨꯖꯨꯃꯕ: ꯍꯥꯌꯔꯤꯕꯥ ꯑꯅꯤꯃꯛ ꯑꯁꯤ ꯑꯈꯟꯅꯕꯥ ꯃꯈꯂꯒꯤ ꯄ꯭ꯔꯣꯇꯤꯅꯁꯤꯡꯅꯤ꯫ ꯃꯦꯗꯤꯁꯤꯅꯗꯥ ꯑꯩꯈꯣꯌꯅꯥ ꯍꯥꯌꯔꯤꯕꯥ ꯃꯣꯅꯣꯛꯂꯣꯅꯦꯜ ꯑꯦꯟꯇꯤꯕꯣꯗꯤꯁꯤꯡ ꯑꯁꯤ . ꯃꯈꯣꯌꯁꯤꯡ ꯑꯁꯤ ꯄꯥꯟꯗꯝ ꯑꯗꯨꯗꯥ ꯊꯦꯡꯅꯔꯤꯕꯥ ꯃꯤꯁꯥꯏꯜ ꯑꯅꯤ ꯑꯣꯏꯅꯥ ꯈꯅꯕꯤꯌꯨ꯫ ꯃꯈꯣꯌꯅꯥ ꯑꯩꯈꯣꯌꯒꯤ ꯍꯀꯆꯥꯡꯗꯥ ꯆꯪꯂꯀꯄꯥ ꯃꯇꯃꯗꯥ ꯃꯈꯣꯌꯅꯥ ꯀꯦꯟꯁꯔ ꯁꯦꯂꯁꯤꯡ ꯊꯤꯅꯕꯥ ꯍꯀꯊꯦꯡꯅꯅꯥ ꯆꯠꯂꯤ꯫ ꯃꯈꯣꯌꯅꯥ ꯀꯦꯟꯁꯔ ꯁꯦꯂꯁꯤꯡ ꯑꯗꯨꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯆꯦꯜꯂꯤ, ꯃꯈꯣꯌꯕꯨ ꯍꯦꯅꯒꯠꯂꯀꯄꯥ ꯊꯤꯡꯏ ꯅꯠꯠꯔꯒꯥ ꯃꯥꯡꯍꯟ ꯇꯥꯀꯍꯅꯕꯥ ꯐꯥꯎꯏ꯫ ꯍꯥꯌꯔꯤꯕꯁꯤꯡ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯏꯐꯦꯛꯇꯤꯕ ꯑꯣꯏꯕꯥ ꯂꯥꯌꯦꯡꯁꯤꯡꯅꯤ ꯃꯔꯃꯗꯤ ꯃꯈꯣꯌꯅꯥ ꯍꯀꯆꯥꯡ ꯐꯕꯥ ꯁꯦꯂꯁꯤꯡꯗꯥ ꯌꯥꯝꯅꯥ ꯑꯃꯥꯡ-ꯑꯇꯥ ꯊꯣꯀꯍꯟꯗꯅꯥ ꯀꯦꯟꯁꯔ ꯁꯦꯜ ꯈꯛꯇꯗꯥ ꯄꯥꯟꯗꯝ ꯊꯝꯂꯤ꯫
  • ꯍꯥꯌꯑꯦꯂꯨꯔꯣꯅꯤꯗꯦꯖ: ꯃꯁꯤ ꯑꯍꯨꯃꯁꯨꯕꯥ ꯑꯃꯅꯤ꯫ ꯃꯁꯤꯅꯥ ꯇꯧꯔꯤꯕꯥ ꯑꯁꯤ ꯃꯊꯛꯇꯥ ꯄꯅꯈ꯭ꯔꯤꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯅꯤ ꯑꯁꯤ ꯑꯩꯈꯣꯌꯒꯤ ꯍꯀꯆꯥꯡꯅꯥ ꯍꯦꯟꯅꯥ ꯐꯅꯥ ꯁꯣꯀꯍꯅꯕꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯏ꯫ ꯅꯣꯔꯃꯦꯜ ꯑꯣꯏꯅꯥ, ꯍꯤꯗꯥꯛ ꯑꯅꯤ ꯑꯗꯨ ꯏꯅꯠꯔꯥꯚꯦꯅꯁ ꯑꯣꯏꯅꯥ (ꯚꯦꯟ ꯑꯃꯗꯥ) ꯄꯤꯕꯗꯥ ꯃꯇꯝ ꯁꯥꯡꯅꯥ ꯆꯪꯏ꯫ ꯑꯗꯨꯕꯨ ꯍꯥꯌꯑꯦꯂꯨꯔꯣꯅꯤꯗꯦꯖ ꯀꯧꯕꯥ ꯑꯁꯤꯅꯥ ꯃꯔꯝ ꯑꯣꯏꯗꯨꯅꯥ ꯍꯤꯗꯥꯛ ꯑꯅꯤꯃꯛ ꯑꯁꯤ ꯈꯣꯡꯒꯤ ꯃꯈꯥꯗꯥ ꯏꯆꯝ ꯆꯝꯕꯥ ꯏꯅꯖꯦꯀꯁꯟ ꯑꯃꯥ ꯑꯣꯏꯅꯥ ꯑꯃꯨꯛ ꯍꯟꯅꯥ ꯄꯤꯕꯥ ꯉꯃꯈ꯭ꯔꯦ꯫ ꯃꯁꯤꯅꯥ ꯑꯅꯥꯕꯥ ꯑꯗꯨꯒꯤꯗꯃꯛ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯂꯩꯕꯥ ꯅꯨꯡꯉꯥꯏꯇꯕꯥ ꯑꯃꯁꯨꯡ ꯃꯇꯝ ꯌꯥꯝꯅꯥ ꯍꯟꯊꯍꯜꯂꯤ꯫

ꯑꯗꯨꯅꯥ, ꯃꯤꯑꯣꯏ ꯑꯍꯨꯝ ꯑꯁꯤꯅꯥ ꯄꯨꯟꯅꯥ ꯂꯥꯀꯃꯤꯟꯅꯗꯨꯅꯥ ꯐꯦꯁꯒꯣ ꯀꯧꯕꯥ ꯁꯛꯇꯤ ꯂꯩꯔꯕꯥ ꯂꯥꯌꯦꯡ ꯑꯁꯤ ꯁꯦꯃꯒꯠꯂꯤ꯫

ꯂꯥꯏꯌꯦꯡ ꯍꯧꯗ꯭ꯔꯤꯉꯩꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯍꯧꯗ꯭ꯔꯤꯉꯩꯒꯤ ꯃꯃꯥꯡꯗꯥ, ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯃꯠꯇꯥ ꯂꯣꯠꯁꯤꯟꯗꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯃꯄꯨꯡꯐꯥꯕꯥ ꯍꯀꯁꯦꯂꯒꯤ ꯍꯤꯁ꯭ꯇꯔꯤ ꯑꯗꯨ ꯈꯟꯅ-ꯅꯩꯅꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯈꯥꯗꯥ ꯄꯤꯔꯤꯕꯥ ꯀꯟꯗꯤꯁꯅꯁꯤꯡ ꯑꯁꯤꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯑꯃꯍꯦꯛꯇꯥ ꯂꯩꯔꯕꯗꯤ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯁꯣꯌꯗꯅꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ:

  • ꯍꯥꯔꯠ ꯗꯤꯖꯤꯖ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯃꯥꯡꯗꯥ ꯂꯩꯔꯝꯕꯥ ꯍꯥꯔꯇꯀꯤ ꯀꯟꯗꯤꯁꯟ ꯑꯃꯥ ꯅꯠꯠꯔꯒꯥ ꯍꯥꯔꯠ ꯐꯦꯜ ꯑꯣꯏꯕꯥ ꯑꯣꯏꯔꯕꯗꯤ꯫
  • ꯍꯥꯏ ꯕ꯭ꯂꯗ ꯄ꯭ꯔꯦꯁꯔ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯍꯥꯏ ꯕ꯭ꯂꯗ ꯄ꯭ꯔꯦꯁꯔ ꯂꯩꯔꯕꯗꯤ꯫
  • ꯍꯥꯔꯇꯀꯤ ꯈꯣꯡꯖꯦꯜ ꯌꯥꯡꯕꯥ (irregular heartbeat): ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯃꯥꯡꯗꯥ ꯀꯩꯗꯧꯉꯩꯗꯥ ꯑꯦꯕꯅꯣꯔꯃꯦꯜ ꯑꯣꯏꯕꯥ ꯍꯥꯔꯇꯀꯤ ꯈꯣꯟꯖꯦꯜ ꯑꯃꯥ ꯂꯩꯔꯝꯂꯕꯗꯤ꯫
  • ꯂꯪꯁ ꯅꯠꯠꯔꯒꯥ ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯒꯤ ꯂꯥꯌꯅꯥꯁꯤꯡ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯒꯤ ꯂꯥꯌꯅꯥꯁꯤꯡ ꯍꯥꯌꯕꯗꯤ ꯑꯦꯖꯃꯥ ꯂꯩꯔꯕꯗꯤ꯫
  • ꯑꯦꯂꯥꯔꯖꯤ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯀꯁꯤꯡ ꯑꯁꯤꯈꯛꯇꯗꯥ ꯅꯠꯇꯅꯥ ꯑꯇꯩ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯀꯁꯤꯡ, ꯆꯤꯟꯖꯥꯀꯁꯤꯡ, ꯗꯥꯏꯑꯦꯠꯁꯤꯡ ꯅꯠꯠꯔꯒꯥ ꯄ꯭ꯔꯤꯖꯥꯔꯕ ꯇꯧꯕꯥ ꯌꯥꯕꯥ ꯄꯣꯠꯁꯀꯁꯤꯡꯒꯤ ꯑꯦꯂꯥꯔꯖꯤ ꯂꯩꯔꯕꯗꯤ ꯑꯩꯈꯣꯌꯗꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ꯫
  • ꯃꯤꯔꯣꯅꯕꯥ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯤꯔꯣꯜꯂꯤꯕꯥ, ꯃꯤꯔꯣꯅꯕꯥ ꯍꯣꯠꯅꯔꯕꯗꯤ ꯅꯠꯠꯔꯒꯥ ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯋꯥꯈꯜ ꯋꯥꯕꯥ ꯂꯩꯔꯕꯗꯤ ꯃꯁꯤ ꯃꯔꯨꯑꯣꯏꯅꯥ ꯃꯔꯨꯑꯣꯏ . ꯑꯃꯁꯨꯡ ꯇꯁꯦꯡꯕꯗꯤ, ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯈꯣꯝꯂꯥꯡ ꯄꯤꯊꯀꯄꯥ ꯃꯃꯥ ꯑꯃꯥ ꯑꯣꯏꯔꯕꯗꯤ .

ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯑꯁꯤ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯄꯤꯕꯅꯥ ꯃꯍꯥꯀꯄꯨ ꯁꯥꯐꯅꯥ ꯑꯃꯁꯨꯡ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯏꯐꯦꯛꯇꯤꯚ ꯑꯣꯏꯅꯥ ꯂꯥꯏꯌꯦꯡꯕꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯒꯅꯤ꯫

ꯃꯁꯤꯒꯤ ꯚꯦꯛꯁꯤꯟ ꯑꯁꯤ ꯀꯔꯝꯅꯥ ꯄꯤꯕꯒꯦ ꯑꯃꯁꯨꯡ ꯅꯍꯥꯛꯅꯥ ꯈꯪꯖꯤꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯈꯣꯡꯒꯤ ꯃꯈꯥꯗꯥ ꯏꯅꯖꯦꯀꯁꯟ ꯑꯃꯥ ꯑꯣꯏꯅꯥ ꯄꯤ꯫ ꯃꯁꯤ ꯃꯍꯧꯁꯥꯅꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯜ ꯅꯠꯠꯔꯒꯥ ꯀ꯭ꯂꯤꯅꯤꯛ ꯑꯃꯗꯥ ꯇ꯭ꯔꯦꯟ ꯇꯧꯔꯕꯥ ꯃꯦꯗꯤꯀꯦꯜ ꯄ꯭ꯔꯣꯐꯦꯁꯅꯦꯜ ꯑꯃꯅꯥ ꯄꯤ꯫ ꯑꯗꯨꯝ ꯑꯣꯏꯅꯃꯛ, ꯀꯦꯁ ꯈꯔꯗꯗꯤ ꯇ꯭ꯔꯦꯟ ꯇꯧꯔꯕꯥ ꯍꯦꯂꯊ ꯋꯥꯔꯀꯔ ꯑꯃꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯌꯨꯃꯗꯥ ꯂꯥꯛꯇꯨꯅꯥ ꯚꯦꯛꯁꯤꯟ ꯑꯗꯨ ꯄꯤꯕꯥ ꯌꯥꯏ꯫

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯩꯅꯥ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛꯀꯤ ꯗꯣꯖ ꯑꯃꯥ ꯁꯣꯟꯊꯔꯕꯗꯤ ꯀꯔꯤ ꯇꯧꯒꯅꯤ?

ꯂꯥꯏꯌꯦꯡ ꯑꯁꯤꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯇꯤꯀꯥ ꯑꯁꯤ ꯃꯇꯝ ꯆꯥꯅꯥ ꯂꯧꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯔꯝ ꯈꯔꯗꯒꯤ ꯅꯍꯥꯛꯅꯥ ꯇꯤꯀꯥ ꯑꯗꯨ ꯃꯇꯝ ꯆꯥꯅꯥ ꯂꯧꯕꯥ ꯉꯃꯗ꯭ꯔꯕꯗꯤ, ꯈꯨꯗꯛꯇꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯐꯣꯟ ꯇꯧꯕꯤꯌꯨ ꯑꯃꯁꯨꯡ ꯃꯈꯣꯌꯗꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ꯫

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯩꯅꯥ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛ ꯌꯥꯝꯅꯥ ꯂꯧꯔꯕꯗꯤ ꯀꯔꯤ ꯇꯧꯒꯅꯤ?

ꯃꯁꯤ ꯃꯍꯧꯁꯥꯅꯥ ꯑꯣꯏꯗꯦ, ꯃꯔꯃꯗꯤ ꯃꯁꯤ ꯄ꯭ꯔꯣꯐꯦꯁꯅꯦꯜ ꯑꯃꯅꯥ ꯑꯦꯗꯃꯤꯅꯤꯁ꯭ꯠꯔꯦꯠ ꯇꯧꯏ꯫ ꯑꯗꯨꯝ ꯑꯣꯏꯅꯃꯛ, ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯑꯣꯡ ꯑꯃꯗꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯊꯀꯈ꯭ꯔꯦ ꯍꯥꯌꯅꯥ ꯈꯜꯂꯕꯗꯤ, ꯋꯥꯈꯜ ꯅꯨꯡꯉꯥꯏꯇꯕꯥ ꯂꯩꯔꯣꯏꯗꯕꯅꯤ ꯑꯃꯁꯨꯡ ꯈꯨꯗꯛꯇꯥ ꯀꯣꯂꯝꯕꯣ ꯅꯦꯁꯅꯦꯜ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯂꯩꯕꯥ ꯅꯦꯁꯅꯦꯜ ꯄꯣꯏꯖꯅꯁ ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯁꯦꯟꯇꯔꯗꯥ ꯐꯣꯟ ꯇꯧꯕꯤꯌꯨ . ꯅꯠꯠꯔꯒꯥ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯅꯀꯄꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯒꯤ ꯏꯃꯔꯖꯦꯟꯁꯤ ꯇ꯭ꯔꯤꯇꯃꯦꯟꯇ ꯌꯨꯅꯤꯠ (ETU)ꯗꯥ ꯆꯠꯂꯨ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯑꯉꯥꯡꯁꯤꯡꯗꯥ ꯄꯤꯕꯥ ꯉꯃꯒꯗ꯭ꯔꯥ?

ꯃꯁꯤꯒꯤ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯃꯍꯧꯁꯥꯅꯥ ꯑꯍꯜ ꯑꯣꯏꯔꯕꯥ ꯃꯤꯑꯣꯏꯁꯤꯡꯗꯥ ꯄꯤ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯉꯥꯡꯁꯤꯡꯗꯥ ꯄꯤꯔꯕꯗꯤ ꯑꯈꯟꯅꯕꯥ ꯀꯦꯌꯔ ꯃꯊꯧ ꯇꯥꯏ꯫ ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯑꯉꯥꯡꯒꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯇꯥꯟꯅꯧ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯂꯧꯕꯥ ꯃꯇꯃꯗꯥ ꯃꯔꯨꯑꯣꯏꯅꯥ ꯆꯦꯀꯁꯤꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ:

  • ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯃꯦꯗꯤꯀꯦꯜ ꯆꯦꯀꯑꯞ ꯇꯧꯕꯥ: ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯂꯧꯔꯤꯉꯩꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯇꯥꯀꯄꯤꯔꯀꯄꯒꯤ ꯃꯇꯨꯡꯏꯟꯅꯥ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯆꯦꯀꯑꯞ ꯇꯧꯕꯤꯌꯨ꯫ ꯅꯍꯥꯛꯀꯤ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯑꯗꯨ ꯍꯦꯟꯅꯥ ꯐꯒꯠꯂꯛꯂꯤꯕ꯭ꯔꯥ ꯅꯠꯠꯔꯒꯥ ꯍꯦꯟꯅꯥ ꯐꯒꯠꯂꯛꯂꯤꯕ꯭ꯔꯥ ꯍꯥꯌꯕꯗꯨ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯋꯥꯔꯤ ꯁꯥꯕꯤꯌꯨ꯫ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯍꯥꯔꯇꯀꯤ ꯐꯉ꯭ꯀꯁꯅꯒꯨꯝꯕꯥ ꯄꯣꯠꯁꯀꯁꯤꯡ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯌꯦꯡꯁꯤꯅꯒꯅꯤ꯫
  • ꯃꯤꯔꯣꯅꯕꯥ ꯊꯤꯡꯕꯥ (ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏꯕꯥ): ꯃꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ . ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯆꯥꯔꯤꯉꯩꯗꯥ ꯑꯃꯁꯨꯡ ꯂꯥꯏꯌꯦꯡ ꯂꯦꯄꯈ꯭ꯔꯕꯥ ꯃꯇꯨꯡꯗꯥ ꯊꯥ 7 ꯐꯥꯎꯕꯥ ꯃꯤꯔꯣꯅꯕꯥ ꯊꯤꯡꯒꯗꯕꯅꯤ꯫ ꯍꯤꯗꯥꯛ ꯑꯁꯤꯅꯥ ꯄꯣꯀꯄꯥ ꯑꯉꯥꯡ ꯑꯗꯨꯗꯥ ꯁꯥꯊꯤꯕꯥ ꯑꯃꯥꯡ-ꯑꯇꯥ ꯊꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ꯫ ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯃꯇꯝ ꯑꯁꯤꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯏꯐꯦꯛꯇꯤꯚ ꯑꯣꯏꯕꯥ ꯕꯔꯊ ꯀꯟꯠꯔꯣꯜ ꯃꯦꯊꯗ ꯑꯗꯨꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯇꯥꯟꯅꯧ꯫
  • ꯑꯇꯣꯞꯄꯥ ꯍꯤꯗꯥꯀꯁꯤꯡꯒꯥ ꯏꯟꯇꯔꯦꯛꯁꯅꯁꯤꯡ: ꯅꯍꯥꯛꯅꯥ ꯂꯧꯔꯤꯕꯥ ꯑꯇꯩ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯀꯁꯤꯡ, ꯍꯔꯕꯁ, ꯚꯤꯇꯥꯃꯤꯅꯁꯤꯡ ꯑꯃꯁꯨꯡ ꯁꯞꯂꯤꯃꯦꯟꯇꯁꯤꯡꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯜꯂꯨ꯫ ꯀꯦꯃꯣꯊꯦꯔꯥꯄꯤ ꯗ꯭ꯔꯒ ꯈꯔꯗꯤ, ꯍꯥꯌꯕꯗꯤ ꯗꯥꯎꯅꯣꯔꯨꯕꯤꯁꯤꯟ, ꯗꯣꯛꯁꯣꯔꯨꯕꯤꯁꯤꯟ, ꯑꯃꯁꯨꯡ ꯑꯦꯄꯤꯔꯨꯕꯤꯁꯤꯅꯅꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯏꯟꯇꯔꯦꯛꯇ ꯇꯧꯕꯥ ꯌꯥꯏ꯫ ꯅꯍꯥꯛꯅꯥ ꯂꯧꯔꯤꯕꯥ ꯈꯨꯗꯤꯡꯃꯛ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫

ꯍꯤꯗꯥꯛ ꯑꯗꯨꯒꯤ ꯑꯣꯏꯊꯣꯀꯄꯥ ꯌꯥꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯁꯤꯡ ꯑꯗꯨ ꯀꯔꯤꯅꯣ?

ꯍꯤꯗꯥꯛ ꯑꯃꯍꯦꯛꯇꯒꯨꯝꯅꯥ, ꯃꯁꯤꯒꯤ ꯑꯃꯅꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ ꯈꯔꯥ ꯊꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ꯫ ꯑꯗꯨꯕꯨ ꯃꯤꯄꯨꯝ ꯈꯨꯗꯤꯡꯃꯛꯅꯥ ꯃꯈꯣꯌꯁꯤꯡ ꯑꯁꯤ ꯐꯪꯗꯦ꯫ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯋꯥꯐꯃꯗꯤ ꯑꯗꯨꯒꯨꯝꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯁꯤꯡ ꯑꯗꯨ ꯀꯔꯤꯅꯣ ꯑꯃꯁꯨꯡ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯈꯣꯌ ꯊꯣꯛꯂꯕꯗꯤ ꯀꯔꯤ ꯇꯧꯒꯗꯒꯦ ꯍꯥꯌꯕꯗꯨ ꯈꯪꯖꯤꯅꯕꯥ ꯑꯁꯤꯅꯤ꯫

ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ꯫ ꯃꯁꯛ ꯈꯪꯗꯣꯀꯄꯥ ꯑꯃꯁꯨꯡ ꯀꯔꯤ ꯇꯧꯒꯗꯒꯦ꯫
ꯈꯨꯗꯛꯇꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯔꯤꯄꯣꯔꯠ ꯇꯧꯒꯗꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯁꯤꯡ꯫
ꯑꯦꯂꯥꯔꯖꯤꯒꯤ ꯔꯤꯑꯦꯛꯁꯅꯁꯤꯡ꯫ ꯈꯣꯡ-ꯈꯨꯠ ꯁꯣꯛ-ꯄꯅꯕꯥ, ꯈꯣꯡ-ꯈꯨꯠ ꯁꯣꯛ-ꯄꯅꯕꯥ, ꯃꯥꯌ, ꯊꯕꯥꯛ ꯅꯠꯠꯔꯒꯥ ꯈꯣꯡꯗꯥ ꯁꯣꯀꯄꯥ꯫
ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯥ ꯋꯥꯕꯥ꯫ ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯥ ꯋꯥꯕꯥ, ꯈꯣꯡ ꯍꯥꯝꯕꯥ, ꯀꯣꯛ ꯆꯤꯀꯄꯥ꯫
ꯍꯥꯔꯇꯀꯤ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ꯫ ꯈꯣꯡꯗꯥ ꯁꯣꯀꯄꯥ, ꯈꯣꯡ ꯍꯥꯝꯕꯥ, ꯈꯪꯍꯧꯗꯅꯥ ꯑꯔꯨꯝꯕꯥ ꯍꯦꯅꯒꯠꯂꯀꯄꯥ, ꯈꯣꯡ ꯅꯠꯠꯔꯒꯥ ꯈꯣꯡꯗꯥ ꯁꯣꯀꯄꯥ꯫
ꯑꯇꯣꯞꯄꯥ ꯁꯥꯊꯤꯕꯥ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ꯫ ꯃꯤꯠ ꯎꯗꯕꯥ, ꯋꯥꯈꯜ ꯃꯥꯡꯈꯤꯕꯥ, ꯂꯥꯏꯍꯧ ꯅꯠꯠꯔꯒꯥ ꯆꯤꯀꯄꯥ, ꯃꯁꯥ ꯃꯊꯟꯇꯥ ꯑꯁꯣꯛ-ꯑꯄꯟ ꯊꯣꯀꯄꯥ, ꯃꯁꯥ ꯃꯊꯟꯇꯥ ꯋꯥꯈꯜ ꯇꯥꯗꯕꯥ, ꯑꯆꯝꯕꯥ ꯃꯑꯣꯡꯗꯥ ꯋꯥꯈꯜ ꯇꯥꯗꯕꯥ꯫
ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯗꯨ ꯂꯦꯡꯗꯅꯥ ꯂꯩꯔꯕꯗꯤ ꯅꯠꯠꯔꯒꯥ ꯁꯣꯀꯍꯜꯂꯕꯗꯤ, ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯜꯂꯨ꯫
ꯗꯥꯏꯖꯦꯁ꯭ꯇꯤꯚ ꯁꯤꯁ꯭ꯇꯦꯃꯒꯤ ꯄ꯭ꯔꯣꯕ꯭ꯂꯦꯃꯁꯤꯡ꯫ ꯗꯥꯏꯔꯤꯌꯥ, ꯅꯣꯡꯃꯩ ꯀꯥꯞꯄꯥ, ꯈꯣꯡ ꯍꯥꯝꯕꯥ꯫
ꯍꯀꯆꯥꯡꯒꯤ ꯑꯅꯥꯕꯥ꯫ ꯁꯔꯨ ꯇꯥꯡꯒꯤ ꯑꯅꯥꯕꯥ, ꯃꯁꯜ ꯁꯣꯟꯊꯕꯥ꯫
ꯑꯇꯣꯞꯄꯥ ꯑꯄꯤꯀꯄꯥ ꯐꯤꯆꯔꯁꯤꯡ꯫ꯆꯨꯝꯅꯥ ꯁꯣꯀꯄꯥ, ꯂꯥꯎꯕꯥ, ꯏꯅꯖꯦꯀꯁꯟ ꯇꯧꯔꯤꯕꯥ ꯃꯐꯝ ꯑꯗꯨꯗꯥ ꯁꯣꯀꯄꯥ ꯅꯠꯠꯔꯒꯥ ꯁꯣꯀꯄꯥ, ꯖꯦꯅꯦꯔꯦꯜ ꯐꯤꯖꯤꯀꯦꯜ ꯐꯤꯇꯁ꯫

ꯂꯤꯁ꯭ꯠ ꯑꯁꯤꯗꯥ ꯑꯣꯏꯊꯣꯀꯄꯥ ꯌꯥꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ ꯄꯨꯝꯅꯃꯛ ꯌꯥꯎꯗꯦ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯑꯇꯣꯞꯄꯥ ꯇꯣꯉꯥꯅꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯑꯆꯝꯕꯥ ꯄꯣꯠꯁꯛ ꯑꯃꯥ ꯎꯔꯕꯗꯤ, ꯃꯗꯨꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯇꯥꯟꯅꯧ꯫

ꯇꯦꯛ-ꯍꯣꯝ ꯃꯦꯁꯦꯖ ꯇꯧꯕꯥ꯫

  • PHESGO ꯑꯁꯤ ꯕ꯭ꯔꯦꯁ꯭ꯠ ꯀꯦꯟꯁꯔꯒꯤ ꯑꯀꯛꯅꯕꯥ, ꯄꯥꯟꯗꯝ ꯊꯝꯂꯤꯕꯥ ꯂꯥꯏꯌꯦꯡ ꯑꯃꯅꯤ꯫ ꯃꯁꯤ ꯗ꯭ꯔꯒ ꯑꯍꯨꯃꯒꯤ ꯀꯝꯕꯤꯅꯦꯁꯟ ꯑꯃꯅꯤ꯫
  • ꯂꯥꯏꯌꯦꯡ ꯍꯧꯗ꯭ꯔꯤꯉꯩꯗꯥ, ꯅꯍꯥꯛꯀꯤ ꯍꯀꯁꯦꯂꯒꯤ ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯄꯨꯝꯅꯃꯛ, ꯃꯔꯨꯑꯣꯏꯅꯥ ꯍꯥꯔꯇꯀꯤ ꯂꯥꯌꯅꯥ, ꯑꯦꯂꯥꯔꯖꯤ ꯑꯃꯁꯨꯡ ꯃꯤꯔꯣꯅꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯜꯂꯨ꯫
  • ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯂꯧꯔꯤꯉꯩꯗꯥ ꯑꯃꯁꯨꯡ ꯊꯀꯄꯥ ꯂꯣꯏꯔꯕꯥ ꯃꯇꯨꯡꯗꯥ ꯊꯥ 7 ꯐꯥꯎꯕꯥ ꯃꯤꯔꯣꯅꯕꯥ ꯊꯤꯡꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫ ꯃꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫
  • ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯥ ꯋꯥꯕꯥ, ꯈꯣꯡꯗꯥ ꯁꯣꯀꯄꯥ, ꯅꯠꯠꯔꯒꯥ ꯃꯥꯌ ꯁꯣꯀꯄꯥ ꯑꯁꯤꯅꯆꯤꯡꯕꯥ ꯁꯥꯊꯤꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ ꯑꯃꯠꯇꯥ ꯂꯩꯔꯕꯗꯤ ꯈꯨꯗꯛꯇꯥ ꯃꯦꯗꯤꯀꯦꯂꯒꯤ ꯄꯥꯎꯇꯥꯛ ꯂꯧꯕꯤꯌꯨ꯫
  • ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯀꯟꯇꯦꯛꯇ ꯇꯧꯗꯨꯅꯥ ꯂꯩꯌꯨ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯀꯤ ꯋꯥꯍꯪꯁꯤꯡ ꯅꯠꯠꯔꯒꯥ ꯋꯥꯈꯜ ꯅꯨꯡꯉꯥꯏꯇꯕꯥ ꯑꯃꯠꯇꯥ ꯂꯩꯔꯕꯗꯤ ꯍꯪꯕꯗꯥ ꯂꯥꯡꯇꯛꯅꯒꯅꯨ꯫ ꯅꯍꯥꯛꯀꯤ ꯌꯥꯏꯐ-ꯊꯧꯔꯥꯡ ꯑꯁꯤ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯃꯔꯨꯑꯣꯏꯕꯅꯤ꯫

PHESGO, Pertuzumab, Trastuzumab, Hyaluronidase, ꯕ꯭ꯔꯦꯁ꯭ꯠ ꯀꯦꯟꯁꯔ, ꯀꯦꯟꯁꯔ ꯂꯥꯌꯦꯡꯕꯥ, ꯃꯣꯅꯣꯛꯂꯣꯅꯦꯜ ꯑꯦꯟꯇꯤꯕꯣꯗꯤ, ꯀꯦꯟꯁꯔ ꯗ꯭ꯔꯒꯁꯤꯡ, ꯅꯨꯄꯤꯁꯤꯡꯒꯤ ꯍꯀꯁꯦꯜ꯫

Frequently Asked Questions (FAQ)

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯑꯉꯥꯡꯁꯤꯡꯗꯥ ꯄꯤꯕꯥ ꯉꯃꯒꯗ꯭ꯔꯥ?

ꯃꯁꯤꯒꯤ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯃꯍꯧꯁꯥꯅꯥ ꯑꯍꯜ ꯑꯣꯏꯔꯕꯥ ꯃꯤꯑꯣꯏꯁꯤꯡꯗꯥ ꯄꯤ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯉꯥꯡꯁꯤꯡꯗꯥ ꯄꯤꯔꯕꯗꯤ ꯑꯈꯟꯅꯕꯥ ꯀꯦꯌꯔ ꯃꯊꯧ ꯇꯥꯏ꯫ ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯑꯉꯥꯡꯒꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯇꯥꯟꯅꯧ꯫

⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No comments yet. Be the first to share your thoughts here.

Add Your Comment

Please calculate: 7 + 6 =